Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Correspondence:
Submit a response
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis
Neurology Göngora-Rivera et al. 66: 436

Data Supplement

Supplemental data; Word document.

Files in this Data Supplement:



This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Correspondence:
Submit a response
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS